Back to search

Ireland· IE-PA-PA1748/001/001

Imunovir 500 mg tablets

A inosine pranobex product containing inosine acedoben dimepranol, registered in Ireland by Kora Corporation Limited trading as Kora Healthcare. The same ATC class is registered in 7 of our 19 countries.

ATC J05AX05

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedImunovir 500 mg tabletsATCJ05AX05REGISTER NO.IE-PA-PA1748/001/001PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Inosine pranobex is registered in 7 of 19 countries.

Countries holding a registration under ATC J05AX05 (inosine pranobex), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 4 of them publish a price we can compare per daily dose

Inosine pranobex · ATC J05AX05

7 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Ireland
  • Japan
  • Norwayprice
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

HPRA (Ireland)
Active substance
Inosine acedoben dimepranol
Manufacturer
Kora Corporation Limited trading as Kora Healthcare
Country
Ireland (IE)
ATC code
J05AX05
ATC class
Inosine pranobex
Defined daily dose
3 g, O
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    PA1748/001/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/afc1267a-aa06-47d9-9523-a44131403bb7
GET /v1/drugs/afc1267a-aa06-47d9-9523-a44131403bb7?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "routes": [
    "Oral use"
  ],
  "source": "hpra",
  "atc_all": [
    "J05AX",
    "J05AX05"
  ],
  "strength": null,
  "pa_number": "PA1748/001/001",
  "substances": [
    "Inosine acedoben dimepranol"
  ],
  "legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Not marketed",
  "authorised_at": "03/11/1983",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

See everything about inosine pranobex.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.